Clinical Trials Browser

Phase 2 × OTHER × Neoplasms × Clear all

NCT06658405 2026-03-18

HPV2

Phase 2 Recruiting

Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

Neoplasms

NCT01198119 2026-03-16

NBI-CAB

Phase 2 Terminated

Mouth Neoplasms, Neoplasms

NCT01042379 2026-03-13

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT01596816 2026-03-13

CKNO-PRO

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT03652298 2026-03-13

NeuroPrevPTSD

Phase 2 Terminated

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

NCT07469683 2026-03-13

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell, Neoplasms

NCT07050771 2026-03-12

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Phase 2 Recruiting

GenitourinaryGynecologic

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Ovarian Neoplasms

NCT06915116 2026-03-06

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Phase 2 Recruiting

Menstruation Disturbances, Neoplasms

NCT06807593 2026-03-05

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

Phase 2 Recruiting

Neoplasms

NCT07205731 2026-03-05

SAFE ESO

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT05065801 2026-03-04

GABRINOX2

Phase 2 Recruiting

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT05681195 2026-03-03

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Phase 2 Recruiting

Neoplasms, Recurrence

NCT06801041 2026-03-03

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasms

NCT06806930 2026-03-03

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Neoplasms

NCT02574728 2026-03-02

AflacST1502

Phase 2 Active not recruiting

CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT05148078 2026-03-02

Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)

Phase 2 Completed

30 enrolled 10 charts

Neoplasms

NCT06435286 2026-03-02

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

Phase 2 Recruiting

Neoplasms

NCT04268277 2026-02-27

Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY

Phase 2 Terminated

22 enrolled 20 charts

Neoplasms, Recurrence, Lymphoma, B-Cell, Marginal Zone

NCT07282834 2026-02-27

Charlie-2

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms, Peritoneal Neoplasms

NCT03755804 2026-02-23

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Phase 2 Active not recruiting

Hodgkin Disease, Neoplasms

NCT07193394 2026-02-23

H3RAKLES

Phase 2 Recruiting

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT04337580 2026-02-20

FASN

Phase 2 Recruiting

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04461509 2026-02-20

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Phase 2 Completed

62 enrolled 11 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05879146 2026-02-19

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

Phase 2 Recruiting

Neoplasms

NCT02693535 2026-02-13

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT03388190 2026-02-13

METIMMOX

Phase 2 Completed

80 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

7 enrolled 14 charts

GastrointestinalHead & Neck

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07406789 2026-02-12

LUMInova

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

NCT06129747 2026-02-09

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Phase 2 Recruiting

Breast Neoplasms, Neoplasms

NCT07227610 2026-02-05

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

Phase 2 Recruiting

Brain Neoplasms, Neoplasms

NCT06417190 2026-02-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Phase 2 Recruiting

Neoplasms

NCT06788938 2026-02-02

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

Phase 2 Recruiting

Neoplasms

NCT07346677 2026-02-02

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Phase 2 Not yet recruiting

Neoplasms, Phlebitis

NCT07381231 2026-02-02

I-APT

Phase 2 Recruiting

Neoplasms

NCT07378761 2026-01-30

CHILURSO

Phase 2 Not yet recruiting

Neoplasms

NCT03943901 2026-01-29

Split-Dose R-CHOP for Older Adults With DLBCL

Phase 2 Active not recruiting

27 enrolled 11 charts

Lymphoma, Neoplasms, Lymphoma, Large B-Cell, Diffuse

NCT02769520 2026-01-28

Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT06323473 2026-01-23

Maitake

Phase 2 Recruiting

Neoplasms

NCT07354919 2026-01-21

AxeCan

Phase 2 Not yet recruiting

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07356791 2026-01-21

REBIRTH-013

Phase 2 Not yet recruiting

Neoplasms

NCT04733534 2026-01-20

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase 2 Active not recruiting

Frailty, Neoplasms

NCT05466994 2026-01-15

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06201884 2026-01-12

APPAHOCA-2

Phase 2 Recruiting

Neoplasms

NCT05152472 2026-01-08

ATEZOGIST

Phase 2 Recruiting

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT07126561 2026-01-08

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Phase 2 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT04795661 2026-01-07

IMHOTEP

Phase 2 Active not recruiting

Neoplasms

NCT07149207 2026-01-07

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Phase 2 Not yet recruiting

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT02286687 2026-01-02

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

Phase 2 Active not recruiting

Neoplasm Metastasis, Neoplasms, Recurrence